Cristália Produtos Químicos Farmacêuticos Ltda.
Quick facts
Marketed products
- Fentanyl Transdermal
Fentanyl acts as an opioid agonist, primarily interacting with mu-opioid receptors in the brain, spinal cord, and other tissues. - Nitroprusside, Sodium · Cardiovascular
Sodium nitroprusside releases nitric oxide, which activates guanylate cyclase to increase cGMP levels, causing vasodilation of both arteries and veins.
Phase 3 pipeline
- bupivacaine S50:R50 plus 8% glucose · Anesthesia
Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. - bupivacaine S75:R25 plus 8% glucose · Anesthesiology
Bupivacaine is a local anesthetic that blocks sodium channels to prevent nerve impulses. - Sodium Enoxaparin clexane · Cardiovascular
Enoxaparin is a low-molecular-weight heparin that inhibits blood clotting by enhancing the activity of antithrombin III against factors Xa and IIa.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Cristália Produtos Químicos Farmacêuticos Ltda. portfolio CI brief
- Cristália Produtos Químicos Farmacêuticos Ltda. pipeline updates RSS
Frequently asked questions about Cristália Produtos Químicos Farmacêuticos Ltda.
What are Cristália Produtos Químicos Farmacêuticos Ltda.'s marketed drugs?
Top marketed products include Fentanyl Transdermal, Nitroprusside, Sodium.
What is Cristália Produtos Químicos Farmacêuticos Ltda.'s pipeline?
Cristália Produtos Químicos Farmacêuticos Ltda. has 3 drugs in Phase 3, 0 in Phase 2, 2 in Phase 1. Late-stage candidates include bupivacaine S50:R50 plus 8% glucose, bupivacaine S75:R25 plus 8% glucose, Sodium Enoxaparin clexane.
Related
- Fentanyl Transdermal
- Nitroprusside, Sodium · Cardiovascular
- Sector hub: All tracked pharma companies